Jasper Therapeutics, Inc.
JSPRHealthcare|Biotechnology|US
$16.86
+2.78 (+19.78%)
DCF Value
$34.77
Tangible Book / Share
$1.48
Cash / Share
$7.65
Clinical Trials (26)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT06053567 Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity. | Nicotine Dependence | P3 | Recruiting | 360 | RCT, Open-label | Nicotine patch |
| NCT06283927 The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302) | Glioblastoma, Glioblastoma Multiforme | Recruiting | 464 | — | Temozolomide, Lomustine | |
| NCT06146738 The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203) | Glioblastoma, Glioblastoma Multiforme | Recruiting | 1,015 | — | — | |
| NCT06118723 The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201) | Glioblastoma, High-grade Glioma | Recruiting | 784 | — | — | |
| NCT03861299 The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients. | Glioblastoma, Glioblastoma Multiforme | N/A | Recruiting | 246 | RCT, Open-label | — |
| NCT07702760 Guideline Implementation and Quality of Care Evaluation in Patients With Heart Failure and Reduced Ejection Fraction (HFrEF) | HFrEF - Heart Failure With Reduced Ejection Fraction, Guideline Adherence | Recruiting | 1,500 | — | — | |
| NCT05467683 CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy | Obsessive-Compulsive Disorder, Post Traumatic Stress Disorder | N/A | Recruiting | 600 | Open-label | — |
| NCT06146725 The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202) | Glioblastoma, Glioblastoma, IDH-wildtype | Recruiting | 564 | — | — | |
| NCT00251030 A Study To Estimate The Effect Of Omeprazole On The Pharmacokinetics Of Nelfinavir In Healthy Subjects | Healthy Volunteers | P4 | Completed | 20 | Open-label | Nelfinavir and Omeprazole |
| NCT06736262 A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants From Jasper-Sponsored Chronic Urticaria Trials | Urticaria Chronic | P2 | Terminated | 67 | Open-label | Briquilimab |
| NCT02963064 JSP191 Antibody Targeting Conditioning in SCID Patients | SCID | P1P2 | Terminated | 23 | Open-label | Humanized anti-CD117 Monoclonal Antibody (JSP191) |
| NCT06162728 Dose Escalation Trial Of Safety, Pharmacokinetic/Pharmacodynamic And Preliminary Clinical Activity of Briquilimab In Adult Patients With Chronic Spontaneous Urticaria (CSU) | Chronic Spontaneous Urticaria | P1P2 | Completed | 87 | RCT, Double-blind | Briquilimab |
| NCT06353971 A Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients With Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment With H1- Antihistamines | Chronic Inducible Urticaria | P1P2 | Terminated | 27 | Open-label | Briquilimab |
| NCT06592768 A Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Briquilimab in Participants With Allergic Asthma | Allergic Asthma | P1 | Terminated | 17 | RCT, Double-blind | Briquilimab |
| NCT04429191 JSP191 Antibody Conditioning Regimen in MDS/AML Subjects Undergoing Allogenic Hematopoietic Stem Cell Transplantation | MYELODYSPLASTIC SYNDROME; MDS, ACUTE MYELOID LEUKEMIA; AML | P1 | Completed | 32 | Open-label | Humanized anti-CD117 Monoclonal Antibody (JSP191) |
| NCT05903274 JSP191 (briquilimab) in Subjects with LR-MDS | Lower-risk Myelodysplastic Syndrome | P1 | Terminated | 6 | Open-label | JSP191 |
| NCT02481752 The Effect of AAT Training in Smokers | Tobacco Use | N/A | Completed | 52 | RCT, Single-blind | — |
| NCT03083353 Isradipine Enhancement of Virtual Reality Cue Exposure for Smoking Cessation | Nicotine Dependence, Smoking, Cigarette | Early P1 | Completed | 78 | RCT, Double-blind | Isradipine |
| NCT03325777 Approach Bias Retraining to Augment Smoking Cessation | Nicotine Dependence | N/A | Completed | 96 | RCT, Open-label | — |
| NCT03083340 Implementation of a Self-Help Depression Program Among Orthopedic Patients | MDD | N/A | Withdrawn | — | Open-label | — |
| NCT02181179 Examining Yoga's Effects on Smoking | Yoga, Waitlist | N/A | Completed | 50 | RCT, Single-blind | — |
| NCT02066792 Dose Timing of D-Cycloserine to Augment CBT for Social Anxiety Disorder | Social Anxiety Disorder | Early P1 | Completed | 152 | RCT, Double-blind | D-Cycloserine, Placebo |
| NCT03080090 YMCA Exercise Intervention for Smoking Cessation Study | Nicotine Dependence | N/A | Completed | 150 | RCT, Open-label | — |
| NCT03152214 Physical Activity and Community Engagement (PACE) Among Returning Veterans | Reintegration | N/A | Completed | 60 | RCT, Single-blind | — |
| NCT02482805 Hormones and Social Anxiety Disorder Treatment | Social Anxiety Disorder | N/A | Completed | 73 | RCT, Single-blind | — |
| NCT03554785 Comparative Effectiveness Research to Improve the Health of Sexual and Gender Minority Patients Through Cultural Competence and Skill Training of Community Health Center Providers and Non-clinical Staff | LGBT Health, Cultural Competency | N/A | Completed | 12 | RCT, Open-label | — |